Eskalith-CR and Ipratropium Inhalation, oral/nebulization
Determining the interaction of Eskalith-CR and Ipratropium Inhalation, oral/nebulization and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lithium
Brand name: Eskalith, Lithobid, Lithonate, Lithotabs, Eskalith-CR
Synonyms: Eskalith-CR (Oral)
Generic Name: ipratropium
Brand name: Atrovent HFA, Atrovent
Synonyms: Ipratropium inhalation, Ipratropium (Oral Inhalation)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Eskalith-CR-Ipratropium nasal
- Eskalith-CR-Ipratropium Nasal 0.03
- Eskalith-CR-Ipratropium Nasal 0.06
- Eskalith-CR-Ipratrovent Sterules
- Eskalith-CR-Iprivask
- Eskalith-CR-IQ Dental Mepivacaine
- Ipratropium Inhalation, oral/nebulization-Eskata
- Ipratropium Inhalation, oral/nebulization-Esketamine
- Ipratropium Inhalation, oral/nebulization-Esketamine Hydrochloride
- Ipratropium Inhalation, oral/nebulization-Esketamine nasal
- Ipratropium Inhalation, oral/nebulization-Eslicarbazepine
- Ipratropium Inhalation, oral/nebulization-Eslicarbazepine Acetate